These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31151137)

  • 1. Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation.
    Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
    Eur J Immunol; 2019 Sep; 49(9):1344-1355. PubMed ID: 31151137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.
    Cella M; Gamini R; Sécca C; Collins PL; Zhao S; Peng V; Robinette ML; Schettini J; Zaitsev K; Gordon W; Bando JK; Yomogida K; Cortez V; Fronick C; Fulton R; Lin LL; Gilfillan S; Flavell RA; Shan L; Artyomov MN; Bowman M; Oltz EM; Jelinsky SA; Colonna M
    Nat Immunol; 2019 Aug; 20(8):980-991. PubMed ID: 31209406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.
    Bernink JH; Krabbendam L; Germar K; de Jong E; Gronke K; Kofoed-Nielsen M; Munneke JM; Hazenberg MD; Villaudy J; Buskens CJ; Bemelman WA; Diefenbach A; Blom B; Spits H
    Immunity; 2015 Jul; 43(1):146-60. PubMed ID: 26187413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.
    Ambrosini P; Loiacono F; Conte R; Moretta L; Vitale C; Mingari MC
    Eur J Immunol; 2015 Jul; 45(7):2061-71. PubMed ID: 25847448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development.
    Goh W; Sudholz H; Foroutan M; Scheer S; Pfefferle A; Delconte RB; Meng X; Shen Z; Hennessey R; Kong IY; Schuster IS; Andoniou CE; Davis MJ; Hediyeh-Zadeh S; Souza-Fonseca-Guimaraes F; Parish IA; Beavis P; Thiele D; Chopin M; Degli-Esposti MA; Cursons J; Kallies A; Rautela J; Nutt SL; Huntington ND
    Nat Immunol; 2024 Feb; 25(2):240-255. PubMed ID: 38182668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.
    Bernink JH; Peters CP; Munneke M; te Velde AA; Meijer SL; Weijer K; Hreggvidsdottir HS; Heinsbroek SE; Legrand N; Buskens CJ; Bemelman WA; Mjösberg JM; Spits H
    Nat Immunol; 2013 Mar; 14(3):221-9. PubMed ID: 23334791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral natural killer cell maturation depends on the transcription factor Aiolos.
    Holmes ML; Huntington ND; Thong RP; Brady J; Hayakawa Y; Andoniou CE; Fleming P; Shi W; Smyth GK; Degli-Esposti MA; Belz GT; Kallies A; Carotta S; Smyth MJ; Nutt SL
    EMBO J; 2014 Nov; 33(22):2721-34. PubMed ID: 25319415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of human natural killer cells and other innate lymphoid cells.
    Montaldo E; Vacca P; Moretta L; Mingari MC
    Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.
    Bjorklund CC; Lu L; Kang J; Hagner PR; Havens CG; Amatangelo M; Wang M; Ren Y; Couto S; Breider M; Ning Y; Gandhi AK; Daniel TO; Chopra R; Klippel A; Thakurta AG
    Blood Cancer J; 2015 Oct; 5(10):e354. PubMed ID: 26430725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innate lymphoid cells].
    Crinier A; Viant C; Girard-Madoux M; Vivier É
    Med Sci (Paris); 2017 May; 33(5):534-542. PubMed ID: 28612730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.
    Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D
    Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
    Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
    Front Immunol; 2019; 10():217. PubMed ID: 30828332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cells.
    Kühnel I; Vogler I; Spreu J; Bonig H; Döring C; Steinle A
    Eur J Immunol; 2024 Apr; 54(4):e2250318. PubMed ID: 38072999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of diverse innate lymphoid cells in human decidua.
    Vacca P; Montaldo E; Croxatto D; Loiacono F; Canegallo F; Venturini PL; Moretta L; Mingari MC
    Mucosal Immunol; 2015 Mar; 8(2):254-64. PubMed ID: 25052762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
    Rodriguez-Rodriguez N; Clark PA; Gogoi M; Ferreira ACF; Kerscher B; Crisp A; Jolin HE; Murphy JE; Sivasubramaniam M; Pedro L; Walker JA; Heycock MWD; Shields JD; Barlow JL; McKenzie ANJ
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2203454119. PubMed ID: 36442116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma.
    Fionda C; Abruzzese MP; Zingoni A; Cecere F; Vulpis E; Peruzzi G; Soriani A; Molfetta R; Paolini R; Ricciardi MR; Petrucci MT; Santoni A; Cippitelli M
    Oncotarget; 2015 Sep; 6(27):23609-30. PubMed ID: 26269456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets.
    Robinette ML; Fuchs A; Cortez VS; Lee JS; Wang Y; Durum SK; Gilfillan S; Colonna M;
    Nat Immunol; 2015 Mar; 16(3):306-17. PubMed ID: 25621825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos.
    Fedele PL; Willis SN; Liao Y; Low MS; Rautela J; Segal DH; Gong JN; Huntington ND; Shi W; Huang DCS; Grigoriadis G; Tellier J; Nutt SL
    Blood; 2018 Nov; 132(20):2166-2178. PubMed ID: 30228232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro model of innate lymphoid cell function and differentiation.
    Allan DS; Kirkham CL; Aguilar OA; Qu LC; Chen P; Fine JH; Serra P; Awong G; Gommerman JL; Zúñiga-Pflücker JC; Carlyle JR
    Mucosal Immunol; 2015 Mar; 8(2):340-51. PubMed ID: 25138665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function.
    Read KA; Jones DM; Freud AG; Oestreich KJ
    Immunol Rev; 2021 Mar; 300(1):82-99. PubMed ID: 33331000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.